Shares of Common Stock RESPONSE GENETICS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • March 15th, 2007 • Response Genetics Inc • In vitro & in vivo diagnostic substances • New York
The undersigned hereby further agrees that, without the prior written consent of the Representative, which consent shall not be unreasonably withheld, during the Lock-Up Period the undersigned will not: (x) file or participate in the filing with the Securities and Exchange Commission of any registration statement, or circulate or participate in the circulation of any preliminary or final prospectus or other disclosure document with respect to any proposed offering or sale of a Relevant Security and (y) exercise any rights the undersigned may have to require registration with the Securities and Exchange Commission of any proposed offering or sale of a Relevant Security.
SERVICES AGREEMENTServices Agreement • March 15th, 2007 • Response Genetics Inc • In vitro & in vivo diagnostic substances • New York
This SERVICES AGREEMENT, dated as of July 30, 2001 (the "Effective Date") by and between Response Genetics, Inc., a Delaware corporation ("Response"), and Taiho Pharmaceutical Co., Ltd., a corporation organized under the laws of Japan, with a principal place of business at 1-27 Kandanishiki-cho, Chiyoda-ku, Tokyo 101-8444, Japan ("Taiho") (Response and Taiho are sometimes hereinafter referred to as the "Parties").
OPTION & LICENSE AGREEMENT USC FILE 2860License Agreement • March 15th, 2007 • Response Genetics Inc • In vitro & in vivo diagnostic substances • California
THIS AGREEMENT is between the UNIVERSITY OF SOUTHERN CALIFORNIA, (hereinafter USC) a California nonprofit corporation with its principal place of business at University Park, Los Angeles, California 90089, and BIOPLAN.COM, INC., a Delaware corporation, with its principal place of business at 405 Lexington Avenue, 23rd Floor, New York, New York 10174 (hereinafter Licensee).
MASTER AGREEMENT FOR THE SUPPLY OF LABORATORY TEST SERVICESMaster Agreement • March 15th, 2007 • Response Genetics Inc • In vitro & in vivo diagnostic substances • New York
GlaxoSmithKline MASTER AGREEMENT FOR THE Biological s.a. Rue de I'lnstitut, 89 SUPPLY OF LABORATORY TEST SERVICES B-1330 Rixensart Belgium Tel. +32 (0) 2 656 81 11 Fax. +32 (0) 2 656 80 00 www.gsk-bio.comMaster Agreement • March 15th, 2007 • Response Genetics Inc • In vitro & in vivo diagnostic substances
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Company’s application requesting confidential treatment under Rule 406 of the Securities Act.
PATENT LICENSE AGREEMENTPatent License Agreement • March 15th, 2007 • Response Genetics Inc • In vitro & in vivo diagnostic substances • California
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Company’s application requesting confidential treatment under Rule 406 of the Securities Act.
Service Provider AgreementService Provider Agreement • March 15th, 2007 • Response Genetics Inc • In vitro & in vivo diagnostic substances • California
This Service Provider Agreement (the "Agreement") is entered into as of September 29, 2006 (the "Effective Date") by and between Affymetrix, Inc., having its principal place of business at 3420 Central Expressway, Santa Clara, CA 95051 ("Affymetrix") and Response Genetics, Inc., having its principal place of business at l640 Marengo Street, Suite 600, Los Angeles, CA 90033 ("Service Provider"), each a "Party," and together the "Parties" to this Agreement.
LICENSE AGREEMENTLicense Agreement • March 15th, 2007 • Response Genetics Inc • In vitro & in vivo diagnostic substances • California
This License Agreement (the "Agreement") is dated as of the 23rd day of November, 2004 (the "Effective Date"), by and between Response Genetics, Inc., located at 1640 Marengo St., Los Angeles, California 90033 ("RGI") and Roche Molecular Systems, Inc., located at 4300 Hacienda Drive, Pleasanton, California 94588 ("RMS").
